NAOMIE LAFLEUR: Open Payments
NPI 1689167579 · LAFAYETTE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,858 in 86 payments from 16 companies in 2025. Trend: 2023 $1,585 · 2024 $1,471 · 2025 $1,858
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 23 | $370 |
| Novartis Pharmaceuticals Corporation | 10 | $207 |
| Shockwave Medical, Inc | 2 | $188 |
| Bard Peripheral Vascular, Inc. | 1 | $152 |
| E.R. Squibb & Sons, L.L.C. | 9 | $140 |
| Novo Nordisk Inc | 9 | $135 |
| Kestra Medical Technology Services, Inc. | 3 | $126 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $110 |
| Amgen Inc. | 6 | $106 |
| Regeneron Healthcare Solutions, Inc. | 3 | $65 |
Products named: LEQVIO, General - Vascular Intervention, Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter, Venclose Maven Catheter, ENROUTE Transcarotid Neuroprotection System, Assure WCD, JARDIANCE, REPATHA.
Industry payments across LA — which companies pay providers there.
